Simply Wall St.
How Inotiv (NOTV) Narrative Is Shifting As Analysts Reset Fair Value Expectations
📉
AI Sentiment
Negative
3/10
- Home
- NOTV
NOTV
Inotiv Inc.
as of 03-09-2026 3:59pm EST
$0.43
+$0.06
+17.37%
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
| Founded: | 1974 | Country: | United States |
| Employees: | N/A | City: | WEST LAFAYETTE |
| Market Cap: | 12.7M | IPO Year: | 1997 |
| Target Price: | $1.50 | AVG Volume (30 days): | 553.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.83 | EPS Growth: | 49.64 |
| 52 Week Low/High: | $0.25 - $3.35 | Next Earning Date: | 05-14-2026 |
| Revenue: | $547,656,000 | Revenue Growth: | 511.19% |
| Revenue Growth (this year): | 5.28% | Revenue Growth (next year): | 5.42% |
| P/E Ratio: | -0.44 | Index: | N/A |
| Free Cash Flow: | -27070000.0 | FCF Growth: | N/A |
Stock Insider Trading Activity of Inotiv Inc. (NOTV)
Leasure Robert Jr.
Sell
President and CEO
NOTV Feb 17, 2026
Avg Cost/Share
$0.30
Shares
16,810
Total Value
$4,963.99
Owned After
1,256,215
SEC Form 4
Sagartz John E
Sell
Chief Strategy Officer
NOTV Feb 17, 2026
Avg Cost/Share
$0.29
Shares
2,119
Total Value
$616.21
Owned After
735,697
SEC Form 4
Taylor Beth
Sell
Chief Financial Officer
NOTV Feb 17, 2026
Avg Cost/Share
$0.29
Shares
2,888
Total Value
$845.90
Owned After
145,480
SEC Form 4
Leasure Robert Jr.
Sell
President and CEO
NOTV Feb 2, 2026
Avg Cost/Share
$0.50
Shares
113,297
Total Value
$57,033.71
Owned After
1,256,215
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Leasure Robert Jr. | NOTV | President and CEO | Feb 17, 2026 | Sell | $0.30 | 16,810 | $4,963.99 | 1,256,215 | |
| Sagartz John E | NOTV | Chief Strategy Officer | Feb 17, 2026 | Sell | $0.29 | 2,119 | $616.21 | 735,697 | |
| Taylor Beth | NOTV | Chief Financial Officer | Feb 17, 2026 | Sell | $0.29 | 2,888 | $845.90 | 145,480 | |
| Leasure Robert Jr. | NOTV | President and CEO | Feb 2, 2026 | Sell | $0.50 | 113,297 | $57,033.71 | 1,256,215 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 9, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 9, 2026 · 100% conf.
AI Prediction BUY
1D
+8.68%
$0.39
5D
+14.35%
$0.41
20D
+22.73%
$0.44
Price: $0.36 Prob +5D: 100% AUC: 1.000
0001628280-26-006192
notv-202602090000720154FALSE00007201542026-02-092026-02-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2026
INOTIV, INC.
(Exact name of registrant as specified in its charter)
Indiana 0-23357 35-1345024 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
2701 KENT AVENUE
WEST LAFAYETTE,INDIANA
47906-1382
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (765) 463-4527 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common SharesNOTVThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
The information provided in Item 2.02 and Item 9.01, including Exhibit 99.1, of this Form 8-K is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.
Item 2.02. Results of Operations and Financial Condition.
On February 9, 2026, Inotiv, Inc. issued a press release announcing financial results for the three months ended December 31, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
Exhibit No.Description
99.1Inotiv, Inc. press release, issued February 9, 2026.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INOTIV, INC.
Date:February 9, 2026By:/s/ Beth A. Taylor Chief Financial Officer, Executive Vice President
2025 Q3 Q3 2025 Earnings
8-K Dec 3, 2025
2025
Q3
Q3 2025 Earnings
8-KDec 3, 2025
0001628280-25-055025
notv-202512030000720154FALSE00007201542025-12-032025-12-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2025
INOTIV, INC.
(Exact name of registrant as specified in its charter)
Indiana 0-23357 35-1345024 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
2701 KENT AVENUE
WEST LAFAYETTE,INDIANA
47906-1382
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (765) 463-4527 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common SharesNOTVThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
The information provided in Item 2.02 and Item 9.01, including Exhibit 99.1, of this Form 8-K is being furnished and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. Item 2.02. Results of Operations and Financial Condition.
On December 3, 2025, Inotiv, Inc. issued a press release announcing financial results for the three and twelve months ended September 30, 2025. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits. (d)Exhibits
Exhibit No.Description
99.1Inotiv, Inc. press release, issued December 3, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INOTIV, INC.
Date:December 3, 2025By:/s/ Beth A. Taylor Chief Financial Officer, Executive Vice President
2025 Q3 Q3 2025 Earnings
8-K Nov 17, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 17, 2025
0001628280-25-052675
notv-202511170000720154FALSE00007201542025-11-172025-11-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): (November 17, 2025)
INOTIV, INC.
(Exact name of registrant as specified in its charter)
Indiana 0-23357 35-1345024 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
2701 KENT AVENUE
WEST LAFAYETTE,INDIANA
47906-1382
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (765) 463-4527 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common SharesNOTVThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 2.02. Results of Operations and Financial Condition.
On November 17, 2025, Inotiv, Inc. (the “Company”) issued a press release providing select preliminary unaudited financial results for the fourth quarter and fiscal year ended September 30, 2025 and disclosing that the presentation by Robert Leasure, Jr., the Company President and Chief Executive Officer, at the Jefferies Global Healthcare Conference is now scheduled for November 18, 2025 at 6:00 a.m. Eastern time. The live webcast and an online replay of Mr. Leasure’s presentation will be accessible in the Investors section of the Company’s web site. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
The information provided in Item 2.02 and Item 9.01, including Exhibit 99.1, of this Form 8-K is being furnished and shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits. (d)Exhibits
Exhibit No.Description
99.1Inotiv, Inc. press release, issued November 17, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
INOTIV, INC.
Date:November 17, 2025By:/s/ Beth A. Taylor Chief Financial Officer, Executive Vice President
Latest Inotiv Inc. News
NOTV Breaking Stock News: Dive into NOTV Ticker-Specific Updates for Smart Investing
Compare NOTV vs Leading Stocks
See how NOTV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NOTV Inotiv Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.